Silverman, Daniel N.
Shah, Sanjiv J.
Article History
First Online: 13 April 2019
Compliance with Ethical Standards
:
: Dr. Silverman reports no conflicts of interest. Dr. Shah reports receiving research grants from the National Institutes of Health (R01 HL107577, R01 HL127028, and R01 HL140731), Actelion, AstraZeneca, Corvia, and Novartis; and has served as a consultant/advisory board member for Abbott, Actelion, AstraZeneca, Amgen, Bayer, Boehringer-Ingelheim, Cardiora, Coridea, CVRx, Eisai, Ionis, Ironwood, Merck, MyoKardia, Novartis, Pfizer, Sanofi, Tenax, and United Therapeutics.
: This article does not contain any studies with human or animal subjects performed by any of the authors.